Biosenta Inc.
ZRO
CNSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -50.00% | 1,050.00% | -66.67% | 100.07% | -99.86% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -50.00% | 1,050.00% | -66.67% | 100.07% | -99.86% |
| Cost of Revenue | -100.00% | 1,500.00% | 0.00% | -50.00% | 0.00% |
| Gross Profit | -100.00% | 600.00% | -50.00% | 100.00% | -99.93% |
| SG&A Expenses | 40.02% | 1.89% | 9.95% | 24.70% | -27.60% |
| Depreciation & Amortization | 0.00% | 0.00% | -20.00% | -20.00% | -20.00% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 39.22% | 2.63% | 14.34% | 25.29% | -29.48% |
| Operating Income | -39.36% | -1.74% | -14.54% | 26.07% | -47.14% |
| Income Before Tax | -32.98% | 19.80% | -1.83% | 11.46% | -8.40% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -32.98% | 19.80% | -1.83% | 11.46% | -8.40% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -32.98% | 19.80% | -1.83% | 11.46% | -8.40% |
| EBIT | -39.36% | -1.74% | -14.54% | 26.07% | -47.14% |
| EBITDA | -39.44% | -1.79% | -14.57% | 26.07% | -47.39% |
| EPS Basic | -164.06% | 19.44% | -0.78% | 16.46% | 7.91% |
| Normalized Basic EPS | -163.75% | 20.00% | 0.00% | 16.50% | 8.05% |
| EPS Diluted | -164.06% | 19.44% | -0.78% | 16.46% | 7.91% |
| Normalized Diluted EPS | -163.75% | 20.00% | 0.00% | 16.50% | 8.05% |
| Average Basic Shares Outstanding | -49.46% | -0.36% | 1.14% | 6.27% | 17.34% |
| Average Diluted Shares Outstanding | -49.46% | -0.36% | 1.14% | 6.27% | 17.34% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |